•
FE
FENC
Fennec Pharmaceuticals Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
262.98M
Volume
71.62K
52W High
$9.92
52W Low
$4.68
Open
$0.00
Prev Close
$7.39
Day Range
0.00 - 0.00
About Fennec Pharmaceuticals Inc. Common Stock
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Latest News
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
GlobeNewswire Inc.•Dec 26
Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada
GlobeNewswire Inc.•Nov 14
Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares
GlobeNewswire Inc.•Nov 14
Fennec Q2 Sales Jump 33 Percent
The Motley Fool•Aug 14
Fennec Announces Results of Annual Meeting
GlobeNewswire Inc.•Jun 3
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
GlobeNewswire Inc.•Feb 7
Fennec Pharmaceuticals Announces Management Change
GlobeNewswire Inc.•Jul 1
Fennec Announces Results of Annual Meeting
GlobeNewswire Inc.•Jun 25